Nuclear Receptors and Cancer Research: Current Trends and Applications

DURATION: 60 MIN

In this webinar, learn about cutting edge research from distinguished professors from Penn State University as they talk about the role of specific nuclear receptors in cancer.

Nuclear receptors have long been a focus in cancer research. The role of dysregulated nuclear receptor mediated signaling pathways in tumorigenesis has been well documented in a variety of cancers. This makes nuclear receptors important therapeutic targets for identifying new therapies to combat cancer.

In this webinar, learn about cutting edge research from distinguished professors from Penn State University as they talk about the role of specific nuclear receptors in cancer, including:

• Aryl Hydrocarbon Receptor (AhR)
• Farnesoid X Receptor (FXR)
• Peroxisome Proliferator-Activated Receptors (PPARα, PPARδ and PPARγ)

Register to hear the featured panelists discuss the function of specific receptors, their mechanisms in various types of cancer and what makes them good therapeutic targets for cancer drug discovery research.

Key Topics Include:

• Learn about mechanisms of nuclear receptors in various types of cancers
• Understand specific receptors and why they are therapeutic targets for cancer drug discovery
• Gain insight into nuclear receptors and the human relevance of animal models